Gastrointestinal tolerability of lornoxicam compared to that of naproxen in healthy male volunteers

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 2, 1996, Pages 151-156

  Aabakken, L ^a   Osnes, M ^a   Frenzel, W ^b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b Nycomed Holdings AS   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

LORNOXICAM; NAPROXEN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; ENDOSCOPY; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER;

EID: 0029981651     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.719899000.x     Document Type: Article

References (20)

1. Paakkari I. Epidemiological and financial aspects of the use of non-steroidal anti-inflammatory analgesics. Pharmacol Toxicol 1994; 75 (Suppl. II): 56-9.
2. Johnson AG, Day RO. The problems and pitfalls of NSAID therapy in the elderly (Part I). Drugs Aging 1991; 1: 130-43.
3. Lichtenstein DR, Syngal S, Wolfe MM. Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract: the double-edged sword. Arthritis Rheum 1995; 1: 5-18.
4. Mohamed AH, Salena BJ, Hunt RH. NSAID-induced gastroduodenal ulcers: exploring the silent dilemma. J Gastroenterol 1994; 29 (Suppl. VII): 34-48.
5. Pruss TP, Stroissnig H, Radhofer-Welte S, et al. Overview of the pharmacological properties, pharmacokinetics and animal safety assessment of lornoxicam. Postgrad Med J 1990; 66 (Suppl. 4): 18-21.
6. Caruso I, Montrone F, Boari L, et al. Lornoxicam versus didofenac in rheumatoid arthritis: a double-blind, multicenter study. Adv Ther 1994; 11: 132-8.
7. Berry H, Bird HA, Black C, et al. A double blind, multicentre, placebo controlled trial of lornoxicam in patients with osteoarthritis of the hip and knee. Ann Rheum Dis 1992; 51: 238-42.
8. Patel A, Skelly AM, Kohn H, Preiskel HVV. Double-blind placebo-controlled comparison of the analgesic effects of single doses of lornoxicam and aspirin in patients with postoperative dental pain. Br Dent J 1991; 170: 295-9.
9. Osnes M, Larsen S, Kidsaunet W, Thom E. Effect of diclofenac and naproxen on gastroduodenal mucosa. Clin Pharmacol Ther 1979; 26: 399-405.
10. Aabakken L. Mucosal damage associated with short term use of non-steroidal anti-inflammatory drugs (thesis). Ullevål Hospital Department of Medicine, Section of Gastroenterology. University of Oslo, Norway, 1990.
11. Lanza FL. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin and other non-steroidal anti-inflammatory agents. Am J Med 1984; 77: 19-24.
12. Aabakken L, Bjørnbeth BA, Hofstad B, Olaussen B, Larsen S, Osnes M. Comparison of the gastrointestinal side effects of naproxen formulations as plain tablets, enteric coated tablets, or enteric coated granules in capsules. Scand J Gastroenterol 1989; 24: 65-75.
13. Aabakken L, Ugstad MB, Gamst ON, Winther R, Osnes M. Naproxen associated gastroduodenal toxicity: enteric coated granules versus plain tablets. Eur J Rheumatol Inflamm 1992; 2: 43-8.
14. Aabakken L, Olaussen B, Mowinckel P, Osnes M. Gastroduodenal lesions associated with two different piroxicam formulations. Scand J Gastroenterol 1992; 27: 1049-54.
15. Carson JL, Strom BL, Morse ML, et al. The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs. Arch Intern Med 1987; 147: 1054-9.
16. García-Rodríguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs. Lancet 1994; 343: 769-72.
17. Todd PA, Clissold SP. Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states. Drugs 1990; 40: 91-137.
18. Larsen S, Aabakken L, Lillevold PE, Osnes M. Assessing soft data in clinical trials. Pharmaceut Med 1991; 5: 29-36.
19. Aabakken L, Larsen S, Osnes M. Visual analogue scales for endoscopic evaluation of NSAID-induced mucosal damage in the stomach and duodenum. Scand J Gastroenterol 1990; 25: 443-8.
20. Aabakken L, Osnes M. Gastroduodenal lesions induced by naproxen : an endoscopic evaluation of regional differences and natural course. Scand J Gastroenterol 1990; 25: 1215-22.